EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel peptide derived from vascular endothelial growth factor prevents amyloid beta aggregation and toxicity

P Bouvet, P de Gea, M Aimard, N Chounlamountri, J Honnorat, J G Delcros, P A Salin, C Meissirel iD

Aging Cell · 2023-09 · 22 (9)

DOI: 10.1111/acel.13907 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, online erschienen am 06.07.2023. Verfasst von P Bouvet und 7 weiteren Autor:innen. Beteiligte Einrichtung: MeLiS, Institut NeuroMyoGène (INMG), Synaptopathies and Autoantibodies, Institut National de la Santé et de la Recherche Médicale (INSERM), U1314, Ce…. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Alzheimer Disease. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Association France Alzheimer, Institut National de la Santé et de la Recherche Médicale.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyloid‐β oligomers (Aβo) are the most pathologically relevant Aβ species in Alzheimer's disease (AD), because they induce early synaptic dysfunction that leads to learning and memory impairments. In contrast, increasing VEGF (Vascular Endothelial Growth Factor) brain levels have been shown to improve learning and memory processes, and to alleviate Aβ‐mediated synapse dysfunction. Here, we designed a new peptide, the blocking peptide (BP), which is derived from an Aβo‐targeted domain of the VEGF protein, and investigated its effect on Aβ‐associated toxicity. Using a combination of biochemical, 3D and ultrastructural imaging, and electrophysiological approaches, we demonstrated that BP strongly interacts with Aβo and blocks Aβ fibrillar aggregation process, leading to the formation of Aβ amorphous aggregates. BP further impedes the formation of structured Aβo and prevents their pathogenic binding to synapses. Importantly, acute BP treatment successfully rescues long‐term potentiation (LTP) in the APP/PS1 mouse model of AD, at an age when LTP is highly impaired in hippocampal slices. Moreover, BP is also able to block the interaction between Aβo and VEGF, which suggests a dual mechanism aimed at both trapping Aβo and releasing VEGF to alleviate Aβo‐induced synaptic damage. Our findings provide evidence for a neutralizing effect of the BP on Aβ aggregation process and pathogenic action, highlighting a potential new therapeutic strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid beta-PeptidesAlzheimer DiseaseMiceAnimalsVascular Endothelial Growth Factor AMemoryLearningSynapsesPeptide Fragments

Stichwörter der Autor:innen

Alzheimer's diseaseVEGFamyloid beta-peptidesblocking peptidesynapsessynaptic transmission

Substanzen

Amyloid beta-PeptidesVascular Endothelial Growth Factor APeptide Fragments

Autor:innen und Institutionen

  • MeLiS, Institut NeuroMyoGène (INMG), Synaptopathies and Autoantibodies, Institut National de la Santé et de la Recherche Médicale (INSERM), U1314, Centre National de la Recherche Scientifique (CNRS), UMR5284, Lyon, Fran…
  • Univ Lyon, Université Claude Bernard Lyon 1, Lyon, France.
  • Centre de Recherche en Cancérologie de Lyon, Apoptosis, Cancer and Development, Institut PLAsCAN, INSERM U1052, CNRS UMR5286, Centre Léon Bérard, Lyon, France.
  • Centre de Recherche en Cancérologie de Lyon, Small Molecules for Biological Targets, INSERM U1052 - CNRS UMR5286, ISPB Rockefeller, Lyon, France.
  • Centre de Recherche en Neurosciences de Lyon, Forgetting Processes and Cortical Dynamics, INSERM U1028, CNRS UMR5292, Bron, France.

ORCID-Profile: C Meissirel

Förderung

  • Association France Alzheimer
  • Institut National de la Santé et de la Recherche Médicale

Zitieren

APA

Bouvet, P., de Gea, P., Aimard, M., Chounlamountri, N., Honnorat, J., Delcros, J. G., Salin, P. A., & Meissirel, C. (2023). A novel peptide derived from vascular endothelial growth factor prevents amyloid beta aggregation and toxicity. Aging Cell, 22(9). https://doi.org/10.1111/acel.13907

Vancouver

Bouvet P, de Gea P, Aimard M, Chounlamountri N, Honnorat J, Delcros JG, et al. A novel peptide derived from vascular endothelial growth factor prevents amyloid beta aggregation and toxicity. Aging Cell. 2023;22(9). doi:10.1111/acel.13907

BibTeX
@article{Bouvet2023,
  author = {Bouvet, P and de Gea, P and Aimard, M and Chounlamountri, N and Honnorat, J and Delcros, J G and Salin, P A and Meissirel, C},
  title = {A novel peptide derived from vascular endothelial growth factor prevents amyloid beta aggregation and toxicity},
  journal = {Aging Cell},
  year = {2023},
  volume = {22},
  number = {9},
  doi = {10.1111/acel.13907}
}
Kostenlos starten →